[1] Biedler JL, Roffler-Tarlov S, Schachner M, et al.Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones[J]. Cancer Res, 1978, 38(11 Pt 1): 3751-3757.
[2] Arenas E, Denham M, Villaescusa JC. How to make a midbrain dopaminergic neuron[J]. Development, 2015, 142(11): 191918-191936.
[3] Nolbrant S, Heuer A, Parmar M, et al.Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation[J]. Nat Protoc, 2017, 12(9): 1962-1979.
[4] Kim TW, Piao JH, Koo SY,et al.Biphasic activation of WNT signaling facilitates the derivation of midbrain dopamine neurons from hESCs for translational use[J]. Cell Stem Cell, 2021, 28(2): 343-355.e5.
[5] Kikuchi T, Morizane A, Doi D, et al.Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model[J]. Nature, 2017, 548(7669): 592-596.
[6] Perrier AL, Tabar V, Barberi T, et al. Derivation of midbrain dopamine neurons from human embryonic stem cells[J]. Proc Natl Acad Sci USA, 2004, 101(34): 12543-12548.
[7] Studer L, Tabar V, McKay RD. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats[J]. Nat Neurosci, 1998, 1(4):290-295.
[8] Arenas E. Wnt signaling in midbrain dopaminergic neuron development and regenerative medicine for Parkinson’s disease[J]. J Mol Cell Biol, 2014, 6(1): 42-53.
[9] Kim J, Su SC, Wang H, et al. Functional integration of dopaminergic neurons directly converted from mouse fibroblasts[J]. Cell Stem Cell, 2011, 9(5): 413-419.
[10] Lindval D, Kokaia Z. Stem cells for the treatment of neurological disorders[J]. Nature, 2006, 441(7097): 1094-1096.